Condition
BRCA Mutation clinical trials and research
As of November 12, 2026, Find a Trial lists 9 BRCA Mutation clinical trials that are recruiting, at sites in 6 countries (most in Italy (3), United States (2), France (1)). By phase: Phase 1/2 (1), Phase 2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 6Countries
Newest BRCA Mutation clinical trials
All recruiting trials (9)
-
Comparing MiniLap and Standard Laparoscopy for Preventive Surgery in BRCA-Mutated Patients
This study tests whether a smaller surgical technique called MiniLap is better than standard laparoscopy for patients with BRCA mutations who are having preventive surgery to remove their ovaries and fallopian tubes.
-
Measuring circulating mutation burden (cfMB) in women with BRCA mutations and their sisters
This trial will test whether a blood test that measures circulating mutation burden (cfMB) differs between cancer-free women who carry a BRCA1/2 mutation and their non-carrier sisters.
-
Using Olaparib for Advanced Prostate Cancer
This study is testing how well the drug olaparib works for men with advanced prostate cancer who have specific genetic changes, to see if it helps them live longer and feel better.
-
SYN818 for advanced or metastatic solid tumors
This Phase 1 study will test oral SYN818 in adults with advanced or metastatic solid tumors, including breast, ovarian, and prostate cancers, whose standard treatments have been exhausted.
-
Polygenic Risk Scores and Early Detection for Ovarian Cancer in BRCA1/2 Carriers
This study tests how women with BRCA1/2 mutations feel about using polygenic risk scores and early-detection tests to guide cancer screening and risk-reducing decisions.
-
Testing a new drug ETX-19477 for advanced solid tumors
This study is testing a new drug called ETX-19477 to see if it can help people with advanced solid tumors that haven't responded to other treatments.
-
Predicting BRCA gene status from healthy ovarian ultrasound images
This study is testing if ultrasound images of healthy ovaries can help predict whether women carry the BRCA gene that increases their risk for breast cancer.
-
New treatment approach for BRCA1/2 mutated triple negative breast cancer
This study is testing a new treatment combining Olaparib and Pembrolizumab for people with BRCA1/2 mutated triple negative breast cancer to see if it works better after chemotherapy.
-
Imaging study using FCH-PET-CT in men with prostate cancer and DNA repair gene mutations
This study is testing if a new type of imaging called FCH-PET-CT can better find cancer spread in men with prostate cancer who have certain gene mutations compared to regular imaging methods.
Related topics
Quick answers
How many BRCA Mutation clinical trials are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in Italy (3 trials), United States (2 trials), France (1 trial), United Kingdom (1 trial), Japan (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.